Mustang Bio Inc.

Mustang Bio Inc. is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for difficult-to-treat cancers and autoimmune diseases. The company’s current programs center on CAR T cell therapies and related oncology platforms designed to target hematologic malignancies, solid tumors, and other serious conditions with high unmet medical need. Mustang Bio works to advance these therapies through research, licensing, and collaboration with medical institutions, positioning itself within the broader precision medicine and immunotherapy markets. Headquartered in Waltham, Massachusetts, Mustang Bio plays a specialized role in the biotechnology sector by translating scientific breakthroughs into potential therapeutic products for patients facing complex and often life-threatening diseases.

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Manuel Litchman M.D.

Employees

4

Headquarters

Waltham, MA, United States

Website

www.mustangbio.com